Home / Neurostimulation solution
Pioneering a paradigm shift for ‘selective’ neural electrical stimulation
Restoring hand grasping movements in patients with complete tetraplegia is the first of Neurinnov’s applications using its groundbreaking technology platform.
Mitigates side-effects
Mastering selective stimulation is the core of Neurinnov’s business. Its ‘generic’ technology platform can stimulate whichever nerve is required to control muscles in upper or lower limbs without side-effects. Mitigating the side-effects that can be induced by a non-selective stimulation is the proof of value.
An embedded ASIC, the key to achieving selective stimulation and the ability to guide the stimulation of a nerve
Casing surrounding the neurostimulator to which electrodes are connected
A controller connected to the implant via an external antenna. The wireless powering of and communication of data with the implanted device is enabled through wireless transcutaneous energy transfer
Software with advanced interfaces to ease the tuning of the neuroprosthesis. Hand biomechanics are complex and selective stimulation is contra intuitive. The software embeds powerful algorithms that overcome these issues
An intuitive patient interface that allows the user to control easily with a very short learning curve, the whole system with discretion and efficiency
Our implantable neurostimulator is specifically designed for a population of patients living with a complete tetraplegia who are ineligible for tendon transfer and orthopedic surgery, the only solution available to date.
Neurinnov’s approach provides them with an implant through which they can control a desired hand movement by using one of four modalities to pilot the neurostimulator device. The patient can choose to open a hand via:
Two patients with complete tetraplegia, a condition of paralysis from the shoulders down, were once again able to grasp objects and perform everyday activities, such as holding a can or eating with fork, through the use of a neurostimulation device designed by Neurinnov under the AGILIS study, led by Inria.
A strong caliber of partners is vital to enabling us to stretch our imaginations. Together, we search for new and improved approaches that advances technological developments in neurostimulation to bring real benefits to underserved medical populations.
Contact
Phone: +33 (0)4 34 34 80 28
Email: contact@neurinnov.com